Latest News about MRNA
Recent news which mentions MRNA
Novavax Stock: Buy, Sell, or Hold in 2023?
November 24, 2022
From Motley Fool
7 Stocks on the Perfect 10 List
November 23, 2022
From InvestorPlace
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
November 22, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 22, 2022
From Benzinga
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark
November 22, 2022
From Benzinga
Confused about COVID boosters? Here’s what the science and the experts say about the new generation of shots.
November 22, 2022
From MarketWatch
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
November 20, 2022
From Motley Fool
The 25 Best Stocks to Buy for Retirement
November 19, 2022
From InvestorPlace
These Wildly Undervalued Stocks Could Go Parabolic
November 19, 2022
From Motley Fool
3 Stocks I'm Planning to Buy Very Soon
November 17, 2022
From Motley Fool
Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say
November 15, 2022
From Benzinga
Cognex, Nucor, Moderna And This Cybersecurity Company Feature On CNBC's 'Final Trades'
November 15, 2022
From Benzinga
Moderna Says Omicron Tailored COVID-19 Shots Shows Better Immune Response Than Original Vaccine
November 14, 2022
Tickers
MRNA
From Benzinga
As new omicron strains overtake BA.5 in the U.S., Biden administration’s public-health emergency may extend into spring
November 14, 2022
Tickers
MRNA
Tags
MRNA
From MarketWatch
The Bear Market Could Go On For Longer If History Proves Right, But 1 Sector Is Bucking The Downturn
November 14, 2022
From Benzinga
Vertex Pharmaceuticals: Buy at the High?
November 14, 2022
From Motley Fool
3 Beaten-Down Stocks to Buy Right Now
November 12, 2022
From Motley Fool
Lordstown Motors, eBay And 2 Other Stocks Insiders Are Selling
November 11, 2022
From Benzinga
Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows
November 11, 2022
From Benzinga
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
November 10, 2022
From Benzinga
5 Companies Buying Back Their Stock Aggressively in This Bear Market
November 10, 2022
From Motley Fool
From Motley Fool
From MarketWatch
5 Cheap Stocks Beginning Investors Can Buy Right Now
November 09, 2022
From Motley Fool
Why Moderna Stock Could Still Be More Than 50% Overvalued
November 09, 2022
Tickers
MRNA
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.